Finance

Lists
Why is AGN down 3,85%?
Dive Deeper
AGN:ASX
Argenica Therapeutics Ltd
0,12 AUD
-3,85%
(-0,0050) 1D
12 ოქტ, 16:00:00 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for AGN...
Open
0,12 AUD
High
0,12 AUD
Low
0,12 AUD
Mkt. cap
16,06 მლნ.
Avg. vol.
67,71 ათ.
Volume
8,21 ათ.
52-wk high
0,34 AUD
52-wk low
0,09 AUD
EPS
-0,01 AUD
Shares outstanding
128,46 მლნ.
Open
0,12 AUD
High
0,12 AUD
Low
0,12 AUD
Mkt. cap
16,06 მლნ.
Avg. vol.
67,71 ათ.
Volume
8,21 ათ.
52-wk high
0,34 AUD
52-wk low
0,09 AUD
EPS
-0,01 AUD
Shares outstanding
128,46 მლნ.
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
12 საათის წინ
This ASX Stock Is Aiming To Treat A Stroke Long Before The Hospital
About Argenica Therapeutics Ltd
CEO-
Employees-
Founded2019
Headquarters-
SectorPharmaceutical industry
Last report
24 ივლ. 2026
Fiscal period
Q4 2026
- / -
Revenue / Est. (AUD)
2,43 მლნ. / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
313,37 ათ.
313,37 ათ.
2,43 მლნ.
2,43 მლნ.
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,52 მლნ.
1,52 მლნ.
588,41 ათ.
588,41 ათ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
739,40 ათ.
739,40 ათ.
643,55 ათ.
643,55 ათ.
Operating expense
2,27 მლნ.
2,27 მლნ.
1,26 მლნ.
1,26 მლნ.
Total operating expenses
2,27 მლნ.
2,27 მლნ.
1,26 მლნ.
1,26 მლნ.
Operating income
-1,96 მლნ.
-1,96 მლნ.
1,17 მლნ.
1,17 მლნ.
Other non operating income
-
-
-
-
EBT including unusual items
-1,91 მლნ.
-1,91 მლნ.
1,23 მლნ.
1,23 მლნ.
EBT excluding unusual items
-1,91 მლნ.
-1,91 მლნ.
1,23 მლნ.
1,23 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
26,46 ათ.
26,46 ათ.
Net income
-1,91 მლნ.
-1,91 მლნ.
1,23 მლნ.
1,23 მლნ.
Net profit margin
-609,00%
-609,00%
50,46%
50,46%
Earnings per share
-
-
-
-
Interest and investment income
46,72 ათ.
46,72 ათ.
59,29 ათ.
59,29 ათ.
Interest expense
-94,00
-94,00
-63,00
-63,00
Net interest expenses
46,62 ათ.
46,62 ათ.
59,23 ათ.
59,23 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები